Published in Zhongguo Yi Xue Ke Xue Yuan Xue Bao on February 01, 2008
Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest (2007) 2.19
Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension. J Heart Lung Transplant (2010) 1.54
A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial. EuroIntervention (2013) 1.53
Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease. J Nucl Med (2008) 1.53
Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int J Cardiol (2007) 1.50
Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation (2003) 1.46
Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials. Can J Cardiol (2013) 1.46
Long-term outcomes of complete versus incomplete revascularization after drug-eluting stent implantation in patients with multivessel coronary disease. Catheter Cardiovasc Interv (2013) 1.42
Is a score of 10 or greater on the Beck Depression Inventory equivalent to clinically diagnosed depression? Int J Cardiol (2012) 1.40
Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. Chin Med J (Engl) (2010) 1.40
Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry. Chin Med J (Engl) (2009) 1.39
Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev (2012) 1.25
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol (2009) 1.22
Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J (2008) 1.15
Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis (2008) 1.08
Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway. Am J Physiol Heart Circ Physiol (2010) 1.04
Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes. JACC Cardiovasc Interv (2010) 1.04
Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev (2012) 1.01
Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review. Chin Med J (Engl) (2011) 0.97
Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. PLoS One (2013) 0.97
Dual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE study. J Interv Cardiol (2014) 0.94
Carbon nanotubes as electrode modifier promoting direct electron transfer from Shewanella oneidensis. Biosens Bioelectron (2009) 0.94
A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study. EuroIntervention (2012) 0.93
Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent? Coron Artery Dis (2007) 0.93
Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study. Evid Based Complement Alternat Med (2013) 0.92
Inflammation may be a bridge connecting hypertension and atherosclerosis. Med Hypotheses (2005) 0.92
Impact of C-reactive protein on in-stent restenosis: a meta-analysis. Tex Heart Inst J (2010) 0.92
Prevalence and clinical characteristics of sleep apnea in Chinese patients with heart failure. Int J Cardiol (2006) 0.89
Letter by Wang et al regarding article, "Childhood air pollutant exposure and carotid artery intima-media thickness in young adults". Circulation (2013) 0.88
Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines. Microvasc Res (2006) 0.87
Surgical outcome and clinical follow-up in patients with symptomatic myocardial bridging. Chin Med J (Engl) (2007) 0.87
Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin. Cytokine (2007) 0.86
Pulmonary function testing in patients with pulmonary arterial hypertension. Respir Med (2009) 0.86
Statins and stem cell modulation. Ageing Res Rev (2012) 0.85
Efficacy and safety of FIREHAWK® abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort. Chin Med J (Engl) (2013) 0.84
Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts. Circ J (2011) 0.84
Endoplasmic reticulum stress caused by left ventricular hypertrophy in rats: effects of telmisartan. Am J Med Sci (2011) 0.84
The emerging role of dipeptidyl peptidase-4 inhibitors in cardiovascular protection: current position and perspectives. Cardiovasc Drugs Ther (2013) 0.84
Effects of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and clinical outcome in patients with acute coronary syndromes undergoing stent-based coronary intervention. Chin Med J (Engl) (2013) 0.84
Electrode potential regulates cytochrome accumulation on Shewanella oneidensis cell surface and the consequence to bioelectrocatalytic current generation. Biosens Bioelectron (2010) 0.84
Prognostic Value of Coronary Artery Stenoses, Markis Class, and Ectasia Ratio in Patients with Coronary Artery Ectasia. Cardiology (2015) 0.83
Enhancing anti-inflammatory cytokine IL-10 may be beneficial for acute coronary syndrome. Med Hypotheses (2005) 0.83
Comparison of diagnostic accuracy and radiation dose between prospective triggering and retrospective gated coronary angiography by dual-source computed tomography. Am J Cardiol (2011) 0.83
Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research. Heart Fail Rev (2014) 0.83
The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension. Hypertens Res (2009) 0.82
Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina. Clin Chim Acta (2005) 0.82
A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis. Chin Med J (Engl) (2006) 0.82
Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction. Cardiovasc Ther (2011) 0.82
PB/PANI-modified electrode used as a novel oxygen reduction cathode in microbial fuel cell. Biosens Bioelectron (2010) 0.82
Diagnostic accuracy of dual-source CT coronary angiography with prospective ECG-triggering on different heart rate patients. Eur Radiol (2011) 0.81
The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway. Int J Cardiol (2012) 0.81
Anti-DNA antibody modified coronary stent for plasmid gene delivery: results obtained from a porcine coronary stent model. J Gene Med (2010) 0.81
Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel. Eur J Heart Fail (2006) 0.81
Tongxinluo decreases apoptosis of mesenchymal stem cells concentration-dependently under hypoxia and serum deprivation conditions through the AMPK/eNOS pathway. J Cardiovasc Pharmacol (2014) 0.80
Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry. Int J Cardiol (2007) 0.80
Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study. EuroIntervention (2014) 0.80
Remote periconditioning reduces myocardial no-reflow by the activation of K ATP channel via inhibition of Rho-kinase. Int J Cardiol (2008) 0.80
Comparison of coronary CT angiography and stress/rest myocardial perfusion SPECT imaging in a Chinese population. Clin Nucl Med (2013) 0.80